Thursday, March 06, 2014 7:03:06 PM
Don't get me wrong. I have quite a bit in negative revenue biotechs that have significant market caps. I have been in and out of NV$X.
Just wondering why speculating is discouraged down on fundamentals in one sector but not in the other...
MCIG is 2/3 through their first quarter after a very short pilot late last year. Maybe if they can get their revenue up to 7-8 mm (possible based on selling and delivering 700k+ of their $10 units) they can get to facebook type ratios. It seems from your posts you are high on them no? Or do I misunderstand all of this? TIA for your advice & answer!
Recent BTZI News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:00:04 PM
- Form C-AR - Annual Report • Edgar (US Regulatory) • 05/31/2024 02:50:06 PM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM